Evosep webinar

Evosep One in the proteomics core facility

THURSDAY, FEBRUARY 29, 2024 at 16:00 CET (10:00 EST)

In this webinar you can learn how the Evosep One can be used to enable proteomics core facilities to expedite research. Focused on standardization and quality control, these facilities benefit well from the core features of the Evosep One. The system is designed to deliver high-quality and reliable data by using standardized workflows and automated sample loading. Proteomics core facilities provide centralized expertise essential for researchers.

These facilities can serve as collaborative hubs, granting access to cutting-edge instrumentation and skilled professionals, fostering an environment of innovation that accelerates scientific breakthroughs. With a versatile scope, proteomics core facilities support a wide range of research needs, from biomarker discovery to drug development and understanding cellular signaling pathways.

Join us for an in-depth look at the possibilities of using the Evosep One in proteomics core facilities, and how our technology offers er great fit when standardization and quality control are crucial to achieve reliable data.

SPEAKERS

Meeting the analytical challenges of data quality and data consistency within a centralized Proteomics Core Facility

Talk by Erik Soderblom, Director, Proteomics and Metabolomics Core Facility, Duke University School of Medicine

Proteomics Core Facilities are commonly utilized within institutions to centralize personnel expertise and instrumentation technology and are often intended to provide a wide range of support to scientists within that institution. That support often includes vastly different biological questions, variations in starting sample types and sample quantity, and a range of study sizes from a few samples up to hundreds of samples. Progressing through these various studies within any given day can present several analytical challenges, as each could have a different level of performance on an LC-MS system. This presentation will highlight the experimental design considerations and analytical strategies we deploy to meet these challenges and ensure the consistency and quality of the data being generated within our Core Facility environment.

Proteomics view on Finnish disease heritage: the NFKB1 example

Talk by Salla Keskitalo, PhD, Laboratory Chief at Molecular Systems Biology Research Group & Proteomics Unit, University of Helsinki

The HiLIFE Proteomics Unit in Finland offers analysis services that emphasize the quantitative characterization of diverse proteomics samples, ranging from clinical specimens to cell models. The services are accessible to national and international users, directly or via Instruct-ERIC. To showcase our collaborative projects, the presentation will summarize the findings of NFKB1 proteomics. Due to the Finnish Disease Heritage the disease-causing variants of NFKB1 are enriched in the population. We have utilized interactomics and global proteomics to understand disease biology and to identify the molecular signaling pathways affected by these mutations.